Development

Systematic, data-driven science coverage · Friday, July 31, 2026
More from Development
Development

GVV858 Phase 1 Trial: Targeting CCNE1-Amplified Advanced Solid Tumors in Breast and Prostate Cancer

Novel Cancer Therapy GVV858 Enters First-in-Human Trial Targeting Advanced Solid Tumors A first-in-...

Mar 30
Development

DPTX3186 Phase 1 Trial Targets Wnt Pathway in Advanced Solid Tumor Treatment

Novel Wnt Pathway Inhibitor Enters First-in-Human Trial for Solid Tumors Researchers have initiated a first...

Mar 30
Development

Innovent Biologics' IBI3003 Enters First-in-Human Phase I/II Trial for Multiple Myeloma

Novel Multiple Myeloma Therapy Enters First-in-Human Trial Innovent Biologics has initiated a first...

Mar 30
Development

Shanghai Mental Health Center Launches First-in-Human Trial of Innovative SP-101 NMDA Antagonist

Researchers at Shanghai Mental Health Center have initiated a first-in-human clinical trial of SP-101, a novel intravenous non-competitive NMDA receptor antagonist designed to potentially address neuropsychiatric conditions.

Mar 30